Диссертация (1140384), страница 25
Текст из файла (страница 25)
Visca,G.M. Fimia // Proteomics. – 2009. – Vol. 9, № 7. – P. 1901–1915.110.Ishii, Y. Localization of cephalosporinase in Enterobacter cloacae byimmunocytochemical examination / Y. Ishii, M. Ichikawa, K. Yamaguchi, K.Takano, M. Inoue // The Journal of antibiotics. – 1991. – Vol. 44, № 10. – P. 1088–1095.111.Jacoby, G.A. Mechanisms of resistance to quinolones / G.A. Jacoby // ClinicalInfectious Diseases. – 2005. – Vol 41, № 2. – P. 120–126.112.Jacoby, G.A. AmpC β-Lactamases / G.A.
Jacoby // Clinical MicrobiologyReviews. – 2009. – Vol. 22, № 1. – P. 161–182.113.Jalal, S. Molecular mechanisms of fluoroquinolone resistance in Pseudomonasaeruginosa isolates from cystic fibrosis patients / S. Jalal, O. Ciofu, N. Hoiby, N.Gotoh, B. Wretlind // Antimicrobial Agents and Chemotherapy. – 2000. – № 44. –P. 710–712.114.Jana, S. Molecular understanding of aminoglycoside action and resistance / S.Jana, J.K. Deb // Applied Microbiology and Biotechnology.
– 2006. – № 70. – P.140–150.115.Jin, J.S. Emergence of 16S rRNA methylase rmtA in colistin-only-sensitivePseudomonas aeruginosa in South Korea / J.S. Jin, K.T. Kwon, D.C. Moon, J.C.Lee // International Journal of Antimicrobial Agents. – 2009. – № 33. – P.490–491.116.Johansson, А. The detection and verification of carbapenemases usingertapenem and Matrix Assisted Laser Desorption Ionization-Time of Flight159[Электронный ресурс] / А.
Johansson, J. Ekelof, C.G. Giske, M. Sundqvist // BMCMicrobiology.–2014.–Vol.14,№89.–Режимдоступа:https://www.ncbi.nlm.nih.gov/pubmed/24720586.117.Jovcic, B. Emergence of NDM-1 metallo-β-lactamase in Pseudomonasaeruginosa clinical isolates from Serbia / B. Jovcic, Z. Lepsanovic, V. Suljagic, G.Rackov, J. Begovic, L. Topisirovic, M. Kojic // Antimicrobial Agents andChemotherapy. – 2011. – Vol. 55, № 8. – P. 3929–3931.118.Kettner, M. Incidence and mechanisms of aminoglycoside resistance inPseudomonas aeruginosa serotype O11 isolates / M. Kettner, P. Milosovic, M.Hletkova, J. Kallova // Infection. – 1995. – № 23.
– P. 380–383.119.Kim, J.Y. Occurrence and mechanisms of amikacin resistance and itsassociation with β-lactamases in Pseudomonas aeruginosa: a Korean nationwidestudy / J.Y. Kim, Y.J. Park, H.J. Kwon, K. Han, M.W. Kang, G.J. Woo // Journal ofAntimicrobial Chemotherapy.
– 2008. – № 62. – P. 479–483.120.Kipnis, E. Targeting mechanisms of Pseudomonas aeruginosa pathogenesis / E.Kipnis, T. Sawa, J. Wiener‐Kronish // Medecine et Maladies Infectieuses. – 2006. –№ 36. – P. 78–91.121.Kitao, T. Development of an immunochromatographic assay for diagnosing theproduction of IMP-type metallo-β-lactamases that mediate carbapenem resistance inPseudomonas / T. Kitao, T.
Miyoshi-Akiyama, M. Tanaka, K. Narahara, M.Shimojima, T. Kirikae // Journal of Microbiological Methods. – 2011. – Vol. 87, №3. – P. 330–337.122.Knox, J. Phenotypic detection of carbapenemase-producing Enterobacteriaceaeby use of matrix-assisted laser desorption ionization-time of flight massspectrometry and the Carba NP test / J. Knox, S.
Jadhav, D. Sevior, A. Agyekum,M. Whipp, L. Waring, J. Iredell, E. Palombo // Journal of Clinical Microbiology. –2014. – №. 52. – P. 4075–4077.123.Kohler, T. Carbapenem activities against Pseudomonas aeruginosa: respectivecontributions of OprD and efflux systems / T. Kohler, M. Michea-Hamzehpour, S.F.160Epp, J.C. Pechere // Antimicrobial Agents and Chemotherapy. – 1999. – Vol. 43, №2.
– P. 424–427.124.Kong, K.F. Characterization of poxB, a chromosomal-encoded Pseudomonasaeruginosa oxacillinase / K.F. Kong, S.R. Jayawardena, A. Del Puerto, L.Wiehlmann, U. Laabs, B. Tummler, K. Mathee // Gene. – 2005. – № 358. – P. 82–92.125.Kos, V.N. Identification of unique in-frame deletions in OprD among clinicalisolates of Pseudomonas aeruginosa / V.N. Kos, R.E. McLaughlin, H.A. Gardner //Pathogens and Disease.
– 2016. – Vol. 74. – № 4. – ftw031.126.Kumar, A. Evidence of MexT-independent overexpression of MexEF-OprNmultidrug efflux pump of Pseudomonas aeruginosa in presence of metabolic stress// A. Kumar, H.P. Schweizer. – PLoS One. – 2011. – № 6. - e26520.127.Lahiri, S.D. Molecular basis of selective inhibition and slow reversibility ofavibactam against class D carbapenemases: a structure-guided study of OXA-24 andOXA-48 / S.D.
Lahiri, S. Mangani, H. Jahic, M. Benvenuti, T.F. Durand-Reville, F.De Luca, D.E. Ehmann, G.M. Rossolini, R.A. Alm, J.D. Docquier // ACS ChemicalBiology. – 2015. – Vol. 10, № 2. – P. 591–600.128.Lassaux, P. Biochemical and structural characterization of the subclass B1metallo-β-lactamase VIM-4 / P. Lassaux, D.A.K. Traore, E. Loisel, A.
Favier, J.D.Docquier, J.S. Sohier // Antimicrobial Agents and Chemotherapy. – 2011. – Vol. 55,№ 3. – P. 1248–1255.129.Lasserre, C. Efficient detection of carbapenemase activity in Enterobacteriaceaeby matrix-assisted laser desorption ionization-time of flight mass spectrometry inless than 30 minutes / C. Lasserre, L. De Saint Martin, G. Cuzon, P. Bogaerts, E.Lamar, Y. Glupczynski, T. Naas, D. Tande // Journal of Clinical Microbiology. –2015.
– № 53. – P. 2163–2171.130.Lee, H. Insertion sequence-caused large-scale rearrangements in the genome ofEscherichia coli // H. Lee, T.G. Doak, E. Popodi, P.L. Foster, H. Tang // NucleicAcids Research. – 2016. – Vol. 44. – № 15. – P. 7109–7119.161131.Li, H. Structure and function of OprD protein in Pseudomonas aeruginosa:From antibiotic resistance to novel therapies / H.
Li, Y.F. Luo, B.J. Williams, T.S.Blackwell, C.M. Xie // International journal of medical microbiology. – 2012. – Vol.302, № 2. – P. 63–68.132.Li, L. A toluene-tolerant mutant of Pseudomonas aeruginosa lacking the outermembrane protein F / L. Li, T. Komatsu, A. Inoue, K. Horikoshi // Bioscience,Biotechnology, and Biochemistry. – 1995. – Vol. 59, № 12. – P. 2358–2359.133.Li, Y.
A new member of the tripartite multidrug efflux pumps, MexVW-OprM,in Pseudomonas aeruginosa / Y. Li, T. Mima, Y. Komori, Y. Morita, T. Kuroda, T.Mizushima, T.J. Tsuchiya // Journal of Antimicrobial Chemotherapy. – 2003. – №52. – P. 572–575.134.Lister, P.D. Antibacterial-resistant Pseudomonas aeruginosa: clinical impactand complex regulation of chromosomally encoded resistance mechanisms / P.D.Lister, D.J. Wolter, N.D. Hanson // Clinical microbiology reviews. – 2009. – Vol.22, № 4. – P. 582–610.135.Liu, Y.Y. Structural modification of lipopolysaccharide conferred by mcr-1 inGram-negative ESKAPE pathogens / Y.Y. Liu, C.E.
Chandler, L.M. Leung, C.L.McElheny, R.T. Mettus, R.M. Shanks, Y. Doi // Antimicrobial Agents andChemotherapy. – 2017. – Vol. 61, № 6. – e00580-17.136.Llanes C. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolatesof Pseudomonas aeruginosa: a French multicentre study / C. Llanes, C. Pourcel, C.Richardot, P. Plesiat, G.
Fichant, J.D. Cavallo, A. Merens, GERPA Study Group //Journal of Antimicrobial Chemotherapy. - 2013. – Vol. 68, № 8, P. 1763–1771.137.Lopez, C.A. Dynamics of intact MexAB-OprM efflux pump: focusing on theMexA-OprM interface [Электронный ресурс] / C.A. Lopez, T. Travers, K.M. Pos,H.I. Zgurskaya, S. Gnanakaran // Scientific Reports. – 2017. – № 16521. – режимдоступа: https://www.nature.com/articles/s41598-017-16497-w.138.Lopez-Causape, C. Evolution of the Pseudomonas aeruginosa mutationalresistome in an international Cystic Fibrosis clone [Электронный ресурс] / C.162Lopez-Causape, L.M.
Sommer, G. Cabot, R. Rubio, A.A. Ocampo-Sosa, H.K.Johansen, J. Figuerola, R. Canton, T.J. Kidd, S. Molin, A. Oliver // ScientificReports.-2017.–Vol.7,№5555.–Режимдоступа:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514035/.139.Lorenz, A. Insights into host-pathogen interactions from state-of-the-art animalmodels of respiratory Pseudomonas aeruginosa infections / A. Lorenz, V. Pawar,S. Haussler, S.
Weiss // FEBS Letters. – 2016. – V. 590, №21. – P. 3941-3959.140.Lu, S. Nanomechanical response of bacterial cells to cationic antimicrobialpeptides / S. Lu, G. Walters, R. Parg, J.R. Dutcher // Soft Matter. – 2014. – № 10. –P. 1806–1815.141.Macia, M.D. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lunginfections / M.D. Macia, D.
Blanquer, B. Togores, J. Sauleda, J.L. Perez, A. Oliver// Antimicrobial agents and chemotherapy. – 2005. – Vol. 49, № 8. – P. 3382–3386.142.MacLeod, D.L. Aminoglycoside-resistance mechanisms for cystic fibrosisPseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaledtobramycin treatment / Nelson L.E., Shawar R.M., Lin B.B., Lockwood L.G., DirkJ.E., Miller G.H., Burns J.L., Garber R.L.
// Journal of Infectious Diseases – 2000. –№ 181. – P. 1180–1184.143. Mano, Y. Molecular analysis of the integrons of metallo-β-lactamase-producingPseudomonas aeruginosa isolates collected by nationwide surveillance programsacross Japan [Электронный ресурс] / Y. Mano, T. Saga, Y. Ishii, A. Yoshizumi,R.A. Bonomo, K. Yamaguchi, K. Tateda // BMC Microbiology. – 2015.
– Vol. 15,№ 41. – режим доступа: https://www.ncbi.nlm.nih.gov/pubmed/25881168.144.Mao, W. On the mechanism of substrate specificity by resistance nodulationdivision (RND)-type multidrug resistance pumps: the large periplasmic loops ofMexD from Pseudomonas aeruginosa are involved in substrate recognition / W.Mao, M.S. Warren, D.S. Black, T. Satou, T. Murata, T. Nishino, N. Gotoh, O.Lomovskaya // Molecular Microbiology. – 2002.
– Vol. 46, № 3. – P. 889–901.163145.Martinez, J.A. Approach to directed therapy after knowledge of the isolate:carbapenemase-producing Enterobacteriaceae, multidrug-resistant Pseudomonasaeruginosa and carbapenem-resistant Acinetobacter baumannii / J.A. Martinez //Revista Espanola De Quimioterapia. – 2016. – V. 29, № 1. – P. 31–34.146.Maseda, H. Variation of the mexT gene, a regulator of the MexEF-oprN effluxpump expression in wild-type strains of Pseudomonas aeruginosa / H.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
